Impact of anti-tumour necrosis factor alpha treatment on admissions to hospital and days of sick leave in patients with ankylosing spondylitis.

Listing, J

Impact of anti-tumour necrosis factor alpha treatment on admissions to hospital and days of sick leave in patients with ankylosing spondylitis. [electronic resource] - Annals of the rheumatic diseases Dec 2004 - 1670-2 p. digital

Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial

0003-4967

10.1136/ard.2003.017327 doi


Adult
Antibodies, Monoclonal--therapeutic use
Antirheumatic Agents--therapeutic use
Cost of Illness
Double-Blind Method
Female
Follow-Up Studies
Germany
Hospitalization--statistics & numerical data
Humans
Infliximab
Male
Middle Aged
Sick Leave--statistics & numerical data
Spondylitis, Ankylosing--drug therapy
Tumor Necrosis Factor-alpha--antagonists & inhibitors